More Blood Pressure Drugs Recalled
TUESDAY, Sept. 24, 2019 -- The recall of the commonly prescribed blood pressure drug losartan has been expanded once again to include an additional five lots.
The drug, made by Torrent Pharmaceuticals, has been recalled because some lots are contaminated with the cancer-causing chemical N-methylnitrosobutyric acid, according to a company press release.
The drugs added to the recall include lots of Losartan Potassium Tablets, USP, and Losartan Potassium/Hydrochlorothiazide Tablets, USP, all of which have amounts of the contaminant that exceed FDA-recommended levels.
This recall is the fifth for losartan that Torrent has announced this year.
© 2020 HealthDay. All rights reserved.
Posted: September 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.